Radiopharmaceuticals Market

1
Radiopharmaceuticals Market 

• Radiopharmaceuticals Market Trends 2023
  Predicted to Grow at 10.2 CAGR by 2032, Allied
  Market Research

2

• The global radiopharmaceuticals market is driven
  by factors such as rise in prevalence of cancer,
  cardiovascular and neurological disease, increase
  in demand for medical imaging, and increase in
  number of product approval for radiopharmaceutical
  s. However, side effect associated with
  radiopharmaceuticals is hampering the
  radiopharmaceuticals market growth. On the
  contrary, presence of radiopharmaceutical
  industry and increase in RD activities for
  radiopharmaceuticals are expected to offer
  remunerative opportunities for expansion of the
  radiopharmaceuticals market during the forecast
  period. According to the report, the global
  radiopharmaceuticals industry generated 5.2
  billion in 2022, and is anticipated to generate
  13.7 billion by 2032, witnessing a CAGR of 10.2
  from 2023 to 2032.

Prime determinants of growth
3
North America to maintain its dominance by 2032

• Based on region, North America held the highest
  market share in terms of revenue in 2022,
  accounting for more than two-fifths of the global
  radiopharmaceuticals market revenue and is likely
  to dominate the market during the forecast
  period, owing to presence of various
  radiopharmaceutical industries, rise in RD
  activities for radiopharmaceuticals, and increase
  in number of product approvals. However, the
  Asia-Pacific region is expected to witness the
  fastest CAGR of 11.2 from 2023 to 2032, owing to
  increase in incidence of cancer, rise in demand
  for nuclear medicine, advancement in technology
  in medical sector, and rise in RD activities for
  manufacturing of radiopharmaceuticals.

4
(No Transcript)
5
Leading Market Players

• Cardinal Health Inc.
• Curium Pharma
• Eli Lilly and Company
• General Electric Company
• Iso-Tex Diagnostics, Inc.
• Jubilant Pharmova Limited
• Lantheus Holdings, Inc.
• Novartis AG
• Siemens AG
• Bayer
• Request Sample Report- 
• https//www.alliedmarketresearch.com/request-sampl
  e/14827

6
Contact

• David Correa
• 5933 NE Win Sivers Drive205, Portland,
  OR 97220United StatesToll Free
  1-800-792-5285 UK 44-845-528-1300Hong Kong
  852-301-84916India (Pune) 91-20-66346060Fax
  1-855-550-5975help_at_alliedmarketresearch.comWeb
   https//www.alliedmarketresearch.com  Follow Us
  on LinkedIn Twitter